Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...

In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...

Folks discharged the same day as their heart valve replacement had similar outcomes as those who were eligible for same-day ...

ORLANDO, FL—(UPDATED) Through 5 years, TAVI with a self-expanding valve provided clinical outcomes similar to those seen with surgery in an intermediate-risk population, according to continued ...

NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™).

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

Read more about how transcatheter aortic valve implantation results in a higher risk of mortality and stroke compared with surgical replacement.

TAVR is a less invasive procedure than traditional open-heart surgery, offering faster recovery, reduced risk, and shorter ...

Biological age acceleration, independently tied to higher all-cause mortality in patients with moderate-to-severe aortic ...

Your aortic valve is an essential barrier between your heart and your body. When it works properly, the aortic valve is a one-way valve that separates the left ventricle, the main pumping chamber of ...